It is a chemicals private limited company based in New Delhi, Delhi, India, established in 2014.
2014 | New Delhi, Delhi, India | ActiveIndianarise Pharmaceuticals Private Limited, a active private limited company, was established on 03 March 2014 in New Delhi, Delhi, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U24233DL2014PTC265686. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Vijay Nath Tiwari (Director), Jeetendra Kumar (Director), Shyam Pandey Narayan (Director). It holds ₹0.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No. 363 First Floor, Gali Chandi Wali, Pahar Gan, J, New Delhi, Delhi, 110055.
U24233DL2014PTC265686
265686
03 March 2014
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Indianarise Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Nath Tiwari | Director | 03 Mar 2014 | Current |
| Jeetendra Kumar | Director | 03 Mar 2014 | Current |
| Shyam Pandey Narayan | Director | 03 Mar 2014 | Current |
| Rajendra Parsad Pandey | Director | 03 Mar 2014 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indianarise Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 138.33% increase. The company also saw a substantial improvement in profitability, with a 178.65% increase in profit. The company's net worth moved up by a moderate rise of 3.19%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Indianarise Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jul 2016 | Others | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Indianarise Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Indianarise Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indianarise Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Indianarise Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Indianarise Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.50 M with Charge ID 100043979 was registered on 16 Jul 2016. was documented.
The activity Vijay Nath Tiwari was appointed as a Director was appointed as a Director on 03 Mar 2014 & has been associated with this company since 11 years 9 months . was completed.
Progress on Jeetendra Kumar was appointed as a Director was appointed as a Director on 03 Mar 2014 & has been associated with this company since 11 years 9 months . was documented.
Shyam Pandey Narayan was appointed as a Director was appointed as a Director on 03 Mar 2014 & has been associated with this company since 11 years 9 months . was recorded as a recent event.
The CIN of Indianarise Pharmaceuticals Private Limited is U24233DL2014PTC265686.
Indianarise Pharmaceuticals Private Limited is headquartered at House No. 363 First Floor, Gali Chandi Wali, Pahar Gan, J, New Delhi, Delhi, 110055.
Indianarise Pharmaceuticals Private Limited was incorporated on 03 March 2014.
The current directors of Indianarise Pharmaceuticals Private Limited are
The primary industry of Indianarise Pharmaceuticals Private Limited is Manufacturing.
Indianarise Pharmaceuticals Private Limited is unlisted.
The authorized capital of Indianarise Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Indianarise Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX